ŌURA Acquires Veri

ŌURA Acquires Sparta Science to Expand Oura Teams Enterprise Data Platform

October 31, 2024

Healthcare Services

ŌURA, maker of the Oura Ring smart wearable, announced an agreement to acquire Sparta Science, an enterprise software company behind the Trinsic data platform. The deal will enhance ŌURA’s Oura Teams B2B offering by combining Oura Ring biometric data with third-party sources and enabling scalable, enterprise-grade health and performance analytics for enterprise, healthcare, and government customers.

Ōura Acquires Doublepoint to Expand AI-Driven Gesture Recognition Capabilities

March 8, 2026

AI & Machine Learning

Ōura has acquired Doublepoint, a Helsinki-based startup developing AI-driven, biometric gesture recognition technology. The deal is intended to strengthen Ōura’s innovation roadmap and accelerate development of more intuitive, “wearable AI” interaction experiences by combining gesture recognition with Oura Ring sensing.

ŌURA Acquires Proxy in All-Equity Deal

May 9, 2023

Cybersecurity

ŌURA has acquired Proxy, a stealth digital identity signal platform, in an all-equity transaction. The acquisition brings Proxy's biometric-linked identity technology and key employees (including founders) into ŌURA to accelerate innovation in wearable-based identity, payments, access, and privacy-forward features.

Ultrahuman Acquires viO HealthTech to Add OvuSense Ovulation Tech

August 15, 2025

Medical Devices

Ultrahuman has acquired viO HealthTech and launched Cycle & Ovulation Pro for its Ultrahuman Ring AIR, integrating viO's clinically validated OvuSense ovulation-tracking algorithm into the ring using finger-based temperature sensing. viO's technology — developed over 15 years with FDA 510(k) clearance and CE Class IIa certifications — will be offered as a paid subscription across the US, UK, EU, Canada and Australia. The deal brings clinical-grade women's health capability to Ultrahuman's consumer wearable platform to improve cycle and ovulation insights.

Aptiva Medical Acquires VeraMed Health

October 7, 2025

Healthcare Services

Aptiva Medical, a Greenleaf Ventures portfolio company, has completed the acquisition of VeraMed Health. The deal expands Aptiva’s national patient base, strengthens its referral and payor networks, and accelerates its growth in continuous glucose monitoring (CGM) distribution and home-delivery diabetes services.

Merck to Acquire Verona Pharma for Approximately $10 Billion

July 9, 2025

Pharmaceuticals

Merck, through a subsidiary, entered into a definitive agreement to acquire Verona Pharma in a transaction valued at approximately $10 billion (at $107 per ADS). The acquisition is intended to add Ohtuvayre (ensifentrine) to Merck’s cardio-pulmonary pipeline, following FDA approval for COPD in June 2024.